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Spinal cord injury (SCI) frequently provokes serious detri-
mental outcomes because neuronal regeneration is limited 
in the central nervous system (CNS). Thus, the creation 
of a permissive environment for transplantation therapy 
with neural stem/progenitor cells (NS/PCs) is a promis-
ing strategy to replace lost neuronal cells, promote repair, 
and stimulate functional plasticity after SCI. Macrophages 
are important SCI-associated inflammatory cells and a 
major source of secreted factors that modify the lesion 
milieu. Here, we used conditional medium (CM) from 
bone  marrow-derived M1 or M2 polarized macrophages 
to culture murine NS/PCs. The NS/PCs showed enhanced 
astrocytic versus neuronal/oligodendrocytic differen-
tiation in the presence of M1- versus M2-CM. Similarly, 
 cotransplantation of NS/PCs with M1 and M2 macro-
phages into intact or injured murine spinal cord increased 
the number of engrafted NS/PC-derived astrocytes and 
neurons/oligodendrocytes, respectively.  Furthermore, 
when cotransplantated with M2 macrophages, the NS/
PC-derived neurons integrated into the local circuitry and 
enhanced locomotor recovery following SCI. Interest-
ing, engrafted M1 macrophages promoted long-distance 
rostral migration of NS/PC-derived cells in a chemokine 
(C-X-C motif) receptor 4 (CXCR4)-dependent manner, 
while engrafted M2 macrophages resulted in limited 
cell migration of  NS/PC-derived cells. Altogether, these 
findings suggest that the cotransplantation of NS/PCs 
together with polarized macrophages could constitute a 
promising therapeutic approach for SCI repair.
Received 14 January 2015; accepted 4 March 2015; advance online  
publication 21 April 2015. doi:10.1038/mt.2015.46
INTRODUCTION
Because of the limited capacity of the adult central nervous system 
(CNS) to undergo repair following traumatic damage, spinal cord 
injury (SCI) remains a devastating disease with poor functional 
outcomes.1 Cell transplantation therapy is a promising approach 
for promoting repair and functional plasticity after SCI.2 NS/
PCs are regarded as particularly advantageous for transplanta-
tion therapy.3,4 Manipulation of the microenvironment after SCI 
is considered necessary to facilitate the differentiation of engrafted 
NS/PCs into neurons.5,6
Inflammation is a critical pathological process that leads to 
secondary damage after SCI.7,8 Macrophages, like microglia, can 
be polarized under appropriate conditions into at least two main 
subpopulations of cells, M1 macrophages (classically activated, 
proinflammatory macrophages) and M2 macrophages (alterna-
tively activated, anti-inflammatory macrophages),9–11 which can 
lead to neuroinflammation having detrimental or beneficial effects 
after SCI.12–14 Although some reports show that IL-4-activated 
microglia induce NS/PC differentiation into oligodendrocytes, 
and  IFN-γ-activated microglia induce NS/PC differentiation into 
neurons, it is still unknown how polarized macrophages mecha-
nistically trigger the differentiation of NS/PCs into specific prog-
eny cells, either in vitro or in vivo.15
The engagement of the engrafted NS/PCs at injured sites is 
key to the success of cell transplantation therapy after SCI.2,3 The 
proinflammatory microenvironment and several chemokines and 
their receptors (e.g., monocyte chemoattractant protein-1, che-
mokine (C-X-C motif) ligand 12 (CXCL12)/chemokine (C-X-C 
motif) receptor 4 (CXCR4)), as well as inflammatory cytokines 
(e.g., IFN-γ and TNF-α) of the injured spinal cord influence the 
migration of both transplanted and endogenous NS/PCs toward 
the lesion site.16–19 We propose that polarized macrophages are the 
source of at least some of these promigratory factors.
This study analyzed (i) the differentiation of NS/PCs in the 
presence of soluble factors secreted by M1 or M2 macrophages 
in vitro and in vivo and (ii) the migration of engrafted NS/PCs 
cotransplanted with M1 or M2 macrophages in a murine SCI 
model. The results demonstrate that modification of the spinal 
cord environment by polarized macrophages together with  NS/
PC-mediated neurogenesis is an exciting new combinatorial 
approach for the treatment of SCI.
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RESULTS
Macrophage polarization state is maintained over 
time in culture after withdrawal of polarizing factors
Bone marrow-derived macrophages (BMDMs) were obtained 
from bone marrow hematopoietic stem cells after induc-
tion in vitro with macrophage colony-stimulating factor. 
 Fluorescence-activated cell sorting analysis showed that nearly 
99% of the stimulated bone marrow stem cells expressed F4/80, 
a specific marker of macrophages (Supplementary Figure S1a). 
After stimulation of the BMDMs with lipopolysaccharide (LPS) 
plus IFN-γ to yield M1 polarization or IL-4 to yield M2 polariza-
tion states, BMDM-derived M1 and M2 macrophages appeared 
flat with cellular extensions under phase contrast microscopy 
(Supplementary Figure S1b). Most M1 macrophages assumed 
a rounded shape, while M2 macrophages exhibited an elongated 
spindle-like shape. On the other hand, unstimulated BMDMs 
without LPS, IFN-γ, or IL-4 yielded unpolarized M0 macro-
phages with an irregular polygonal morphology (Supplementary 
Figure S1b). The morphological changes of the polarized M1 and 
M2 macrophages were similar to those previously reported by 
McWhorter.20
To further confirm the macrophage polarization state of the 
BMDM-differentiated cells, flow cytometry was used to deter-
mine surface antigen expression(F4/80, CD86, and CD206), 
quantitative polymerase chain reaction (qPCR) and western 
blotting analyses were conducted to evaluate the expression 
of iNOS and CD86, established specific markers of M1 macro-
phages, and arginase 1 (Arg1) and CD206, established specific 
markers of M2 macrophages9,11,21 in macrophages exposed to 
LPS/IFN-γ or IL-4 polarizing stimuli during the first 24 hours of 
culture. Flow cytometrical analysis revealed that macrophages 
activated with LPS/  IFN-γ had increased expression of CD86 
(approximately 43% of  F4/80-positive cells were CD86 positive), 
whereas macrophages activated with IL-4 had increased expres-
sion of CD206 (approximately 84% of F4/80-positive cells were 
CD206 positive) (Supplementary Figure  S1c). Consequently, 
macrophages stimulated with LPS/IFN-γ expressed high mRNA 
levels of inos and cd86, as well as il1β, il6, il12, tnfa,irf5, and 
ifng, but not arg1 or cd206 (Supplementary Figures S1d and 
S2a–f). Conversely, cells stimulated with IL-4 expressed high 
mRNA levels of arg1 and cd206, in addition to il4, il10, and tgfb, 
but not inos or cd86 (Supplementary Figures S1e and Figure 
S2g–l). The protein expression level of iNOS but not of Arg1 
was significantly higher in macrophages stimulated with LPS/
IFN-γ, while the protein level of Arg1 was significantly higher 
in macrophages stimulated with IL-4 (Supplementary Figure 
S1h). These results suggest that BMDMs were sufficiently polar-
ized to become M1 or M2 macrophages after 24-hour stimula-
tion with LPS/IFN-γ or IL-4, as previously reported.21
To harvest the conditional medium (CM) from unpolarized 
M0 and polarized M1/M2 macrophages without exogenous  LPS/
IFN-γ or IL-4, we cultivated the polarized M1 and M2 macro-
phages for 24 hours, as described above. The medium of the polar-
ized M1 and M2 macrophages, as well as that of the unpolarized 
M0 macrophages, was then changed to neurobasal medium with-
out polarizing factors and the macrophages were subjected again 
to another 24 hours of culture.
Next, we verified that the polarized M1/M2 macrophages 
retained their polarized phenotype after the second 24 hours of 
culture using flow cytometry, qPCR and western blot analyses to 
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assess the expression levels of markers specific to the polarized 
states (Supplementary Figure S1c–h). About 38% cells were 
still F4/80+CD86+ among LPS/IFN-γ-activated macrophages. By 
contrast, 26% of cells were F4/80+CD206+ among IL-4-activated 
macrophages (Supplementary Figure S1c). Addittionally, the 
polarized M1 and M2 macrophages still expressed high mRNA 
levels of inos/cd86 (Supplementary Figure S1f) and arg1/cd206 
(Supplementary Figure S1g), respectively, relative to the 
control, unpolarized M0 macrophages. In addition, the M1 
and M2 macrophages continued to secrete high protein levels 
of iNOS and Arg1 into the culture medium (Supplementary 
Figure S1h). The culture medium was collected from the cells 
during the second 24-hour culture period and used as M0-CM, 
M1-CM, and M2-CM for further experiments, as described 
below. Supplementary Figure S1c–h shows that the M1 and 
M2 macrophages maintained their polarized phenotype in vitro 
even after withdrawal of the polarizing triggers, at least for 
some time.
Figure 1  Differentiation of neural stem/progenitor cells (NS/PCs) following stimulation with M0, M1- or M2-CM in vitro. (a,b) Representative 
immunofluorescence images of NS/PCs differentiated into Tuj1-, Oligo2-, and glial fibrillary acidic protein (GFAP)-positive (+) cells without (control, 
CTL) or with the assorted CM samples. The enlarged cells in the lower left-hand corner of each panel show the typical morphology for each culture. 
Space bars = 200 μm. (c–e) Percentage of Tuj1-, Oligo2-, and GFAP-positive cells differentiated from NS/PCs without (control) or with the assorted 
CM samples. (f–h) qPCR analysis of tuj1, pdgfra, and gfap, (i) western blotting of Tuj1, Oligo2, and GFAP (j–l) a densitometric quantitative analysis in 
cells differentiated from NS/PCs without (CTL) or with the assorted CM samples. Data in (c–h) and (j–l) were pooled from three independent experi-
ments (*P < 0.05, **P < 0.01, ***P < 0.001); data in (a, b, and i) are representative of three independent experiments.
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M1-CM-treated NS/PCs are biased toward astrocytic 
differentiation in vitro, whereas M2-CM-treated NS/
PCs are biased toward neuronal and oligodendrocytic 
differentiation
NS/PCs derived from the embryonic spinal cords of both 
 wild-type (WT) and green fluorescent protein (GFP)-transgenic 
mice (TgGFP mice) were cultured to form neurospheres. The 
neurospheres expressed the specific markers of NS/PCs, Sox2, 
and nestin (Supplementary Figure S3a,b). NS/PCs were cultured 
with normal differentiation medium as the control group or with 
M0-CM, M1-CM, or M2-CM as the experimental groups. Tuj1, 
Oligo2/PDGFRα, and glial fibrillary acidic protein (GFAP) were 
used as specific markers of differentiated neurons, oligodendro-
cytes, and astrocytes, respectively (Figure 1a,b).
Immunofluorescence staining showed that the penetra-
tion rates of the differentiated neural cells were similar in the 
control and M0-CM groups, where nearly 25% of the cells 
were Tuj1-postive, >10% were Oligo2-positive, and ~60% were 
 GFAP-positive (Figure 1a–e). However, M1-CM-treated NS/PCs 
were far more biased toward differentiation into  GFAP-positive 
cells than M2-CM-treated NS/PCs, while M2-CM-treated NS/
PCs were more biased toward differentiation into Tuj1- and 
Oligo2-positive cells than M1-CM-treated NS/PCs (Figure 1a,b). 
Quantitative analysis showed that the neural cell differentiation 
Figure 2 Differentiation of engrafted neural stem/progenitor cells (NS/PCs) cotransplanted with M0, M1, and M2 macrophages into the 
intact spinal cord. (a–c) Representative images of NS/PCs derived from GFP-Tg mice and cotransplanted with M0, M1, or M2 macrophages. The 
NS/PCs were differentiated into (a) NeuN-, (b) MBP-, and (c) glial fibrillary acidic protein (GFAP)-positive cells and detected by IHC. The boxed area 
in each image is enlarged at the lower left-hand corner of the panel. Space bars = 50 μm. (d–f) The percentages of (d) NeuN-, (e) MBP-, and (f) 
GFAP-positive cells among the engrafted GFP-expressing NS/PCs are shown. Data in (a–c) are representative of three independent experiments; data 
in (d–f) were pooled from three independent experiments (*P < 0.05, **P < 0.01).
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rates were significantly different between M1- and M2-CM-
treated NS/PCs with respect to Tuj1-postive neurons (~10 ver-
sus 30%, P < 0.001), Oligo2-positive oligodendrocytes (~7 versus 
15%, P  <  0.05) and GFAP-positive astrocytes (~80 versus 50%, 
P < 0.001) (Figure 1c–e).
The M2-CM-differentiated NS/PC-derived cells expressed sig-
nificantly higher mRNA levels of tuj1 than M1-CM-differentiated 
cells (eightfold higher, P  <  0.001), M0-CM-differentiated cells 
(1.8-fold higher, P  <  0.05) or control cells (~2.25-fold higher, 
P < 0.05) (Figure 1f). The mRNA expression level of pdgfra, cor-
responding to platelet-derived growth factor (PDGF) receptor-α 
(PDGFRα) and another specific marker of oligodendrocytes, was 
also significantly higher in M2- than in M1-CM-differentiated 
cells (eightfold higher, P  <  0.01), M0-CM-differentiated cells 
(twofold higher, P  <  0.01) or control cells (fourfold higher, 
P  <  0.01) (Figure  1g). However, the mRNA expression level of 
gfap in M1-CM-differentiated cells was significantly higher than 
that in M2-CM-differentiated cells (1.8-fold higher, P < 0.01), or 
that in M0-CM-differentiated cells and control cells (both three-
fold higher, P < 0.001) (Figure 1h).
The protein expression levels of Tuj1 and Oligo2 were also 
 significantly higher in M2-CM-differentiated cells than in the 
untreated control or M0-CM-differentiated cells; however, this 
was not the case for M1-CM-differentiated cells (Figure  1i–k). 
By contrast, the protein expression levels of GFAP were sig-
nificantly higher in M1- than in M2-CM-differentiated, 
 M0-CM-differentiated, or untreated control cells (Figure 1i and l). 
The results of qPCR and western blotting analyses (Figure 1i–l) 
were consistent with those of immunofluorescence staining 
(Figure 1a,b), and show that NS/PCs cultured with CM derived 
Figure 3 Sustainability of engrafted macrophages in the M0, M1, and M2 polarization states. (a–f) Expression of iNOS (a, c, and e) and Arg1 
(b, d, and f) in engrafted neural stem/progenitor cells (NS/PCs) and (a and b) M0, (c and d) M1, and (e and f) M2 macrophages at 3 days after 
transplantation. The boxed area in each image is enlarged at the lower left-hand corner of the panel. Space bars = 200 μm. (g and h) The percentage 
of (g) RFP+iNOS+ (h) RFP+Arg1+ cells among the engrafted red fluorescent protein (RFP)-positive macrophages are shown. (i) Western blot analysis of 
polarized macrophage markers (iNOS and Arg1) and neural lineage markers (Tuj1, Oligo2, and glial fibrillary acidic protein (GFAP)) in tissue dissected 
from the injured spinal cord containing engrafted NS/PCs and M0, M1, or M2 macrophages. (j and k) Densitometric analysis of iNOS and Arg1 pro-
tein expression levels in (i). (l–n) Densitometric analysis of Tuj1, Oligo2, and GFAP protein expression levels. Data in (a–i) are representative of three 
independent experiments; data in (g–h and j–n) are pooled from three independent experiments (*P < 0.05, ***P < 0.001).
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from macrophages under any of the polarization states differenti-
ated primarily into astrocytes (penetration rate > 50% for M0, M1, 
and M2 macrophages). However, NS/PCs cultured with M1-CM 
were more likely to generate astrocytes in vitro, while NS/PCs 
cultured with M2-CM were more likely to generate neurons and 
oligodendrocytes.
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Differentiation of engrafted NS/PCs cotransplanted 
with polarized macrophages into the intact spinal cord
To investigate how polarized macrophages influence the differen-
tiation of NS/PCs in vivo, we first transplanted NS/PCs together 
with M0, M1, or M2 macrophages into the intact adult murine 
spinal cord. The NS/PCs were derived from GFP-transgenic mice 
as described above, and the macrophages were derived from red 
fluorescent protein (RFP)-transgenic mice generated previously 
by our research group.22
At 12 weeks post-transplantation, a large number of 
 GFP-positive cells was found in the spinal cord tissue (Figure 2a–c), 
while RFP-positive engrafted M0, M1, and M2 macrophages 
were too scarce to be detected (data not shown). The percent-
age of NeuN-positive differentiated neurons generated from 
the NS/PCs was significantly higher in the engrafted M2 + NS/
PC group than in the engrafted M0  +  NS/PC group (22 versus 
17%, P < 0.05) or the engrafted M1 + NS/PC group (22 versus 5%, 
P < 0.01) (Figure 2a and d). A comparison of the M0 + NS/PC and 
M1 + NS/PC groups yielded a smaller number of NeuN-positive 
neurons in the latter (17 versus 5%, P < 0.01) (Figure 2a and d). 
These results suggest that M2 macrophages, but not M1 macro-
phages, encourage NS/PCs to differentiate into neurons following 
transplantation into the intact spinal cord.
Oligodendrocytic differentiation was also more prominent 
in the engrafted M2 + NS/PC and M0 + NS/PC groups than in 
the engrafted M1  +  NS/PC group, as assessed by myelin basic 
protein (MBP) expression (Figure 2b and e). In the M2 + NS/PC 
group, 12% of the transplanted NS/PCs differentiated into MBP-
positive cells, as opposed to only 9% in the M0 + NS/PC group 
(P < 0.05) and 5% in the M1 + NS/PC group (P < 0.01) (Figure 2e). 
Conversely, nearly 90% of the transplanted NS/PCs differentiated 
into GFAP-positive astrocytes in the M1 + NS/PC group, whereas 
73 and 67% of the NS/PCs were GFAP-positive in the M0 + NS/PC 
and M2 + NS/PC groups, respectively (P < 0.01) (Figure 2f). These 
results suggest that exogenous polarized M1 macrophages mainly 
stimulate the differentiation of transplanted NS/PC into astrocytes 
in the intact spinal cord, while M2 macrophages encourage NS/PC 
differentiation into neurons and oligodendrocytes.
Polarized macrophages maintain their phenotype 
after transplantation into the injured spinal cord and 
induce the differentiation of engrafted NS/PCs
SCI triggers the production of proinflammatory cytokines dur-
ing the acute injury phase; the proinflammatory cytokines in 
turn promote the polarization of macrophages into the M1 phe-
notype.13,14,23,24 Therefore, we asked whether M1 and M2 macro-
phages polarized in vitro by LPS/IFN-γ or IL-4 could sustain their 
polarization state after transplantation into the acutely injured 
spinal cord.
To address this question, we first transplanted RFP-positive 
M0, M1, or M2 macrophages into the injured spinal cord at 1 
day postinjury (dpi). At 3 days post-transplantation, the polar-
ization states of the engrafted macrophages were analyzed by 
immunohistochemistry (IHC), revealing a large number of 
transplanted GFP- and RFP-positive cells in the spinal cord tis-
sue (Figure 3a–h). In the M0 + NS/PC group, only a small frac-
tion of the engrafted RFP-positive macrophages expressed iNOS 
or Arg1 (Figure 3a,b and g,h). The distribution of the engrafted 
RFP-positive macrophages was similar to that of iNOS-positive 
cells in the M1 + NS/PC group, where approximately 90% of the 
RFP staining  co-localized with iNOS staining to yield purple-col-
ored cells in the spinal cord sections. However, only about 10% of 
the RFP-positive cells were also Arg1-positive (Figure  3c,d and 
g,h). Therefore, iNOS-positive cells clearly predominated over 
 Arg1-positive cells after cotransplantation of M1 macrophages 
and NS/PCs. By contrast, nearly 80% of Arg1-positive cells were 
prevalent in sections of the injured spinal cord for the M2 + NS/
PC group and colocalized with RFP-positive M2 macrophages, 
whereas  RFP-positive/iNOS-positive cells were less common 
(Figure 3e,f and g,h).
In all sections, no engrafted GFP-positive cells expressed iNOS 
or Arg1, or overlapped with any type of RFP-positive macrophage 
(Figure 3a–f). Western blotting analysis also confirmed that the 
protein expression levels of iNOS were higher in the M1 + NS/
PC group than in the M0 + NS/PC group (1.8-fold, P < 0.05) and 
M2 + NS/PC group (3.1-fold, P < 0.05) (Figure 3i and j). However, 
the protein expression levels of Arg1 were higher in the M2 + NS/
PC group than in the M1 + NS/PC group (2.8-fold, P < 0.05) at 3 
days after transplantation (Figure 3i and k).
In addition to evaluating the expression of macrophage polar-
ization markers, we also investigated the expression levels of 
assorted neural cell markers in the spinal cord. Western blot anal-
ysis showed significantly higher protein expression levels of Tuj1 
and Oligo2, but not GFAP, in the engrafted M2 + NS/PC group 
than in the other groups. By contrast, the engrafted M1  +  NS/
PC group exhibited significantly higher levels of GFAP, but not of 
Tuj1 and Oligo2 (Figure 3i and l–n). Thus, the engrafted, polar-
ized macrophages apparently influenced the differentiation of the 
cotransplanted NS/PCs as early as 3 days after grafting into the 
acutely damaged spinal cord. These observations further suggest 
that the engrafted macrophages are capable of sustaining their 
polarization state for at least the first 3 days in vivo.
Polarized macrophages differentially affect the 
generation of neural cells from engrafted NS/PCs 
after SCI
The differentiation of cotransplanted NS/PCs into neurons, oli-
godendrocytes, and astrocytes was next studied in sections of the 
Figure 4 Differentiation of engrafted neural stem/progenitor cells (NS/PCs) cotransplanted with polarized macrophages into the acutely 
injured spinal cord. (a–c) Representative images of engrafted NS/PCs derived from GFP-Tg mice and cotransplanted with M0, M1, or M2 macro-
phages. The NS/PCs were differentiated into (a) NeuN-, (b) MBP-, and (c) glial fibrillary acidic protein (GFAP)-positive cells and detected by IHC. The 
boxed area in each image is enlarged at the lower left-hand corner of the panel. Space bar = 50 μm. (d–f) The percentages of (d) NeuN-, (e) MBP-, 
and (f) GFAP-positive cells among the engrafted GFP-positive NS/PCs are shown. Data in (a–c) are representative of three independent experiments; 
data in (d–f) were pooled from three independent experiments (*P < 0.05, **P < 0.01). (g) BMS scores were evaluated in SCI mice engrafted with 
NS/PCs and M0, M1, or M2 macrophages (n = 6 mice per group). M2 + NS/PC group versus M1 + NS/PC group, *P < 0.05, **P < 0.01; M2 + NS/
PC group versus M0 + NS/PC group, #P < 0.05. (h) The expression of synapsin is shown in the injured spinal cord in the three experimental groups. 
Space bar = 20 μm.
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injured spinal cord. At 12 weeks after transplantation of the NS/PCs 
together with M0, M1, or M2 macrophages, almost all of the RFP-
positive cells disappeared, leaving behind a preponderance of GFP-
positive cells derived from the engrafted NS/PCs (Figure 4 a –c). 
All three kinds of neural cells were found in the engrafted NS/
PC + M0, NS/PC + M1, and NS/PC + M2 groups; however, the 
number of differentiated neural cells varied from group to group 
(Figure 4a–f).
In the M1 + NS/PC-engrafted group, ~3% of the GFP-positive 
cells were also NeuN-positive. This fraction increased to 9% in the 
M0 + NS/PC group (P < 0.01) and 15% in the M2 + NS/PC group 
(P < 0.01) (Figure 4a and d). The M1 + NS/PC groups also showed 
fewer MBP-positive/GFP-positive cells (2%) than the M0 + NS/
PC group (7%, P < 0.01) or the M2 + NS/PC group (12%, P < 0.01) 
(Figure 4b and e). However, >95% of the GFP-positive cells in the 
M1 + NS/PC group were also GFAP-positive, as opposed to only 
81% (P < 0.05) in the M0 + NS/PC group and 73% (P < 0.01) in the 
M2 + NS/PC group) (Figure 4c and f). These results confirm that 
M1 macrophages enhance the differentiation of engrafted NS/PCs 
into astrocytes, while M2 macrophages enhance their differentia-
tion into neurons and oligodendrocytes.
Locomotor recovery outcomes were examined when NS/PCs 
were co-transplanted with M0, M1, and M2 macrophages into 
the injured spinal cord. Mice cotransplanted with M2 macro-
phages and NS/PCs exhibited significantly higher Basso Mouse 
Scale (BMS) scores than those cotransplanted with M0 or M1 
macrophages and NS/PCs, whereas mice cotransplanted with M1 
macrophages and NS/PCs exhibited the worst locomotor recovery 
and the lowest BMS scores (Figure 4g).
The integration of engrafted NS/PCs into the host neuronal 
circuitry is considered to be of utmost importance for obtaining 
functional recovery in the injured spinal cord.6,25,26 Therefore, we 
next assessed synapsin expression levels after SCI and cell trans-
plantation, because high synapsin content is indicative of synapse 
formation. IHC analysis revealed a few synapsin-positive areas in 
the M0 + NS/PC and M1 + NSC/PC groups that surrounded GFP-
positive cells in a regular array (Figure 4h). The synapsin signals 
also surrounded host-derived  GFP-negative/NeuN-positive cells in 
the M1 + NC/PC group, but not the  NS/PC-derived GFP-positive/
NeuN-positive cells (Figure  4h). On the other hand, synapsin 
expression was greatly increased and found in close contact with 
NeuN-positive cells derived from both the engrafted GFP-positive 
NS/PC-derived cells (yellow staining, inset in Figure 4h) and the 
endogenous GFP-negative host neurons (Figure  4h). Therefore, 
the NS/PC-derived neurons in the M2  +  NS/PC cotransplanted 
group apparently formed synapses with host neurons.
Taken together, the results in Figure 4 suggest that engrafted M2 
macrophages provide an environment in the SCI that is suitable for 
directing NS/PC differentiation to a neuronal/oligodendrocytic cell 
fate with improved locomotor recovery, while engrafted M1 mac-
rophages provide an environment directing NS/PC differentiation 
mainly toward an astrocytic fate with attenuated locomotor recov-
ery. In addition, engrafted M2 macrophages enhanced the integra-
tion of NS/PC-derived neurons into the host neuronal circuitry.
Figure 5 Migratory patterns of engrafted neural stem/progenitor cell (NS/PC)-derived cells in the injured spinal cord after co-transplantation 
of NS/PCs and M0, M1, or M2 macrophages. (a–d) Migration of NS/PCs alone without cotransplanted macrophages (a) and with cotrans-
planted (b) M0, (c) M1, and (d) M2 macrophages. The boxed areas in (a–d) are enlarged in (a’–d’). In a–d, ** denotes the lesion epicenter. Space 
bars = 1 mm. (a’) shows the middle region of the rostral migration stream of the NS/PC-derived cells, while (b’–d’) all show end-regions of the rostral 
migration stream. The arrowheads in (a’–d’) indicate GFP-positive NS/PC-derived cells. Space bar = 50 μm. (e) Statistical results showing the inte-
grated optical density (IOD) and the migration distance (P1, P2, P3, and P4) of engrafted NS/PC-derived cells cotransplanted without or with polar-
ized macrophages in injured spinal cord. M1+NS/PCs versus M2+NS/PCs, P1 < 0.001; NS/PCs versus M2+NS/PCs, P2 < 0.001; M0+NS/PCs versus 
M2+NS/PCs, P3 < 0.001; M0+NS/PCs versus M1+NS/PCs, P4 < 0.01. Statistical data came from three independent experiments. D, dorsal; R, rostral.
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Migratory patterns of NS/PCs cotransplanted with 
polarized macrophages after SCI
In addition to their ability to regulate the differentiation potential 
of NS/PCs in vivo, we also examined the capacity of engrafted M0, 
M1, and M2 macrophages to influence the migratory patterns of 
NS/PC-derived cells in the injured spinal cord. First, NS/PCs were 
transplanted alone or in combination with M0, M1, or M2 macro-
phages into acutely damaged spinal cords to generate four experi-
mental groups. The migration of engrafted GFP-positive  NS/
PC-derived and RFP-positive macrophages were then assessed at 
Figure 6 CXCR4/CXCL12 signaling contributes to the migration of neural stem/progenitor cell (NS/PC)-derived cells in response to polarized 
macrophages. (a–d) The mRNA expression levels of cxcr4 (a and b) and cxcl12 (c and d) are shown in (a and c) M0-, M1-, and M2-CM-treated NS/
PCs and (b and d) M0, M1, and M2 macrophages in vitro. (e) Western blot analysis of CXCR4 expression in M0-, M1-, and M2-CM-treated NS/PCs. 
Spleen tissue was used as the positive control. (f) Quantitative densitometric analysis indicated that M1-CM-treated NS/PCs expressed elevated levels 
of CXCR4. (g) CXCL12 expression in NS/PCs cultured with M0, M1-, or M2-CM, as well as in M0, M1, and M2 macrophages. Space bar = 10 μm. 
(h) IHC images of CXCL12 expression in engrafted NS/PC-derived cells cotransplanted with macrophages into the injured spinal cord. Space bar = 10 
μm. (i) NS/PC migration induced by M0, M1-, or M2-CM in a transwell assay with and without AMD3100. Space bar = 50 μm. Data in (a–d) and 
(f) were pooled from three independent experiments (*P < 0.05, **P < 0.01, ***P < 0.001).
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12 weeks post-transplantation. As described above, RFP-positive 
macrophages were essentially absent from all of the spinal cord 
sections. However, GFP-positive cells showed different migratory 
characteristics in the four experimental groups (Figure 5a–d).
In the NS/PC alone group, the GFP-positive cells migrated 
mainly in the rostral and caudal directions away from the 
 cell-injection site, with a much longer migration distance ros-
trally than caudally (5 versus 2 mm) (Figure  5a and e and 
Supplementary Figure S4a). The GFP-positive cells also migrated 
in the rostral and caudal directions away from the injection site 
in the M0 + NS/PC group, again with a longer distance rostrally-
than caudally (Figure 5b and e and Supplementary Figure S4b). 
Nevertheless, the total migration distance of the GFP-positive 
cells in the M0 + NS/PC group was less than that in the NS/PC 
alone group (4 versus 7 mm) (Figure 5a,b, and e).
The migratory patterns of the NS/PC-derived GFP-positive 
cells differed widely between the M1  +  NS/PC group and the 
M2 + NS/PC group. In the former, the GFP-positive cells mainly 
migrated in the rostral direction over a relatively long dis-
tance (>7 mm), with a caudal migration distance of only ~2 mm 
(Figure 5c and e and Supplementary Figure S4c). In the latter 
case, the GFP-positive cells migrated only a short distance away 
from the injection site in either the rostral or caudal direction 
(Figure 5d and e and Supplementary Figure S4d). The enlarged 
images in Figure 5, A’–D’ revealed GFP-positive cells present in 
the migration stream rather than contributing to long-distance 
axonal growth, as reported recently.27,28 These results imply 
that M1 macrophages promote the long-distance migration of 
engrafted NS/PC-derived cells in the rostral direction, while M2 
macrophages restrict the movement of the NS/PC-derived cells 
and trap them within the injection site.
CXCR4 and CXCL12 participate in the migration of 
engrafted NS/PC-derived cells
CXCL12 (also known as stromal cell-derived factor 1, or SDF-1) 
and its receptor, CXCR4, are key regulators of neuronal migration 
Figure 7 Migratory patterns of engrafted neural stem/progenitor cell (NS/PC)-derived cells after cotransplantation of AMD3100-treated 
NS/PCs and macrophages. (a–d) Migration patterns are shown of (a) NS/PCs transplanted alone and (b–d) NS/PCs cotransplanted with (b) M0 
macrophages, (c) M1 macrophages and (d) M2 macrophages. In a–d, ** denotes the lesion epicenter. (e) Statistical results showing the integrated 
optical density (IOD) and the migration distance (P1, P2, P3, and P4) of engrafted NS/PC-derived cells after cotransplantation of AMD3100-treated 
NS/PCs and macrophages in injured spinal cord. M0+NS/PCs versus M2+NS/PCs, P1 < 0.001; M0+NS/PCs versus M1+NS/PCs, P2 < 0.01; NS/PCs 
versus M2+NS/PCs, P3 < 0.001; M1+ NS/PCs versus M2+NS/PCs, P4 < 0.001. Space bars = 1 mm.
Dorsal
Ventral
Caudal
90
80
70
60
50
40
IO
D 
(in
tag
rat
ed
 op
tic
al 
de
ns
ity
) (
%)
30
20
10
0
−9 −8 −7 −6 −5 −4 −3 −2 −1 0 1 2 3 4 5 6 7 8 (mm)
P1
P2
P3
P4 NS/PC/AMD3100
1 mm
M0+NS/PC/AMD3100
M1+NS/PC/AMD3100
M2+NS/PC/AMD3100
Rostral
CaudalEpicenterRostral
a
b
c
d
e
1086 www.moleculartherapy.org vol. 23 no. 6 jun. 2015
© The American Society of Gene & Cell Therapy
Effects of Polarized Macrophages on Neural Stem Cells
in the developing and injured CNS.29–31 For this reason, we hypoth-
esized that CXCL12/CXCR4 signaling might be involved in the 
migration of the NS/PC-derived cells after cotransplantation of 
parental NS/PCs with polarized macrophages.
We first evaluated this hypothesis by investigating the expres-
sion levels of CXCR4 and CXCL12 in M0, M1, and M2 macro-
phages. We found that the mRNA levels of cxcr4 were higher in M1 
than in M0 or M2 macrophages, and were also higher in M1-CM-
treated NS/PCs than in M0- or M2-CM-treated NS/PCs (Figure 6a 
and b). Western blotting and densitometric analysis confirmed 
that CXCR4 protein expression levels paralleled cxcr4 mRNA 
expression levels in NS/PCs stimulated with  macrophage-derived 
CM (Figure 6e and f). The mRNA and protein expression levels of 
the chemokine C-X-C motif receptor (CXCR7), another receptor 
for CXCL12, were also higher in M1 macrophages and in NS/PCs 
cultured with M1-CM (Supplementary Figure S7).
Contrarily, M2 macrophages expressed significantly higher 
cxcl12 mRNA levels than M0 or M1 macrophages, and NS/PCs 
expressed significantly higher cxcl12 mRNA levels when cultured 
with M2-CM than when cultured with M0- or M1-CM (Figure 6c 
and d). The expression of CXCL12 was also higher in engrafted 
RFP-positive M2 macrophages, but not in M0 or M1 macro-
phages, in the injured spinal cord at 3 days after transplantation 
(Figure 6h). However, only a few NS/PC-derived cells expressed 
CXCL12 in the injured spinal cord (Figure 6h), which may be due 
to low level of expression of CXCL12 protein in NS/PC-derived 
cells. Our results are consistent with those of Jaerve32 and indi-
cate that M2 macrophages (as well as reactive astrocytes) secrete 
CXCL12 after SCI, after which it can bind to CXCR4 on  NS/
PC-derived cells.
Lastly, an in vitro transwell experiment showed that the num-
bers of NS/PC-derived cells stimulated to migrate in response 
to M0- or M2-CM exceeded those migrating in response to 
M1-CM (Figure 6i). These findings signify that NS/PCs are less 
attracted by M1-derived factors than by M0/M2-derived factors 
(e.g., CXCL12 in M2 macrophages). However, the numbers of 
cells passing through the filter membrane in the transwell assay 
were significantly and dose-dependently decreased by treatment 
of the NS/PCs with AMD3100, a specific antagonist of CXCR4 
(Figure  6i). A toxicity assay ruled out the possibility that these 
results stemmed from cytoxicity of AMD3100 toward NS/PCs 
(Supplementary Figure S8). Therefore, CXCL12/CXCR4 signal-
ing probably contributes to the migration of NS/PC-derived cells 
in vivo.
Blockade of CXCR4 influences the migration of 
engrafted NS/PC-derived cells after SCI
The NS/PCs and polarized macrophages were treated with 
AMD3100 to interrupt CXCR4 signaling before cotransplantation 
into the injured spinal cord. At 2 weeks after transplantation, the 
migratory pattern of NS/PC-derived GFP-positive cells treated 
withAMD3100 (Figure  7 and Supplementary Figure S9) was 
quite different from that of untreated NS/PC-derived cells with 
intact CXCR4 signaling (Figure 5). In the NS/PC alone group, the 
migration of the progeny cells occurred in both rostral and cau-
dal directions, with increased rostral migration after AMD3100 
treatment (Figure  7a). However, rostral and caudal migratory 
distances were almost identical (~3 mm) in the M0  +  NS/PC 
group after AMD3100 treatment (Figure 7b and Supplementary 
Figure S9a). By contrast, the GFP-positive cells in the M1 + NS/
PC group displayed almost no migration after AMD3100 admin-
istration (Figure 7c and Supplementary Figure S9b).
To our surprise, the NS/PC-derived GFP-positive cells in the 
M2 + NS/Pc group migrated in the rostral direction by >7 mm after 
AMD3100 treatment (Figure 7d and Supplementary Figure S9c). 
Nonetheless, these cells showed almost no migration without 
CXCR4 blockade (Figure  5d), suggesting that the modulation 
of CXCR4 signaling is essential for the translocation of  NS/
PC-derived progeny after co-transplantation of the parental cells 
with polarized macrophages into the damaged spinal cord.
DISCUSSION
NS/PC transplantation has emerged as one of the most promising 
therapeutic strategies for SCI because of the potential of NS/PCs 
to differentiate into neurons. Given the vulnerability of engrafted 
NS/PCs to pathological environmental forces, many studies have 
emphasized the importance of modifying the pathological micro-
environment of the lesioned spinal cord to improve neuronal dif-
ferentiation after SCI.
Both detrimental and beneficial actions of neuroinflamma-
tion have been reported after SCI,12–14 possibly because different 
types of macrophages/microglia with distinct actions on neuronal 
regeneration are present at the lesion site.13,14,21,33 M1 macrophages 
secrete proinflammatory cytokines and upregulate inducible 
nitric oxide synthase (iNOS) and reactive oxygen species (ROS), 
both of which are neurotoxic and inhibitory to neurite outgrowth 
and axonal extension.14,21 By contrast, M2 macrophages release 
trophic factors and anti-inflammatory cytokines that function 
in neuroprotection and the promotion of neurite extension.14,21,23 
Consistent with the above observations, M2 macrophages are 
considered to favor the functional recovery in the damaged spinal 
cord.14 Moreover, previous work has shown that M1 macrophages 
are more prevalent than M2 macrophages during the acute and 
chronic phases of SCI, whereas M2 macrophages predominate 
during the subacute phase.13,14,21 Previous work indicates that SCI 
triggers the production of proinflammatory cytokines during the 
acute injury phase which in turn promote the polarization of mac-
rophages into the M1 phenotype.13,14,23,24 Here, we found that  RFP-/
iNOS+ area was smaller in the M2+NS/PC group (Figure 3e), pos-
sibly indicating that M2-polarized macrophage can induce endog-
enous microglia/macrophage to M2 polarization. On the basis 
of these results, we propose that functional recovery following 
the combined transplantation of NS/PCs and M2 macrophages 
could be due, at least partly, to an increase in the endogenous M2 
microglia/macrophage pool.
The survival rate of the transplanted cells is crucial for func-
tional recovery; thus, we collected spinal cord tissues at 1 day, 3 
days, 2 weeks, 5 weeks, 9 weeks, and 12 weeks after transplan-
tation to check macrophage polarization and the fate of the NS/
PCs in vivo. At 12 weeks post-transplantation, a large number of 
 GFP-positive cells remained in the spinal cord tissue (Figure 2a–c), 
whereas the number of macrophage cells decreased gradually over 
time, resulting in the gradual loss of RFP-positive engrafted M0, 
M1, and M2 macrophages and failure to detect them at 12 weeks 
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post-transplantation (data not shown). However, our results sug-
gest that the engrafted macrophages were capable of maintaining 
their polarization state for at least the first 3 days in vivo, which 
maybe long enough for the engrafted macrophages to determine 
stem cell fate, as suggested by the results of NS/PC differentiation 
in vitro.
Understanding the mechanisms by which neural stem cells 
give rise to neurons, astrocytes, and oligodendrocytes is a cen-
tral question in stem cell biology. The differentiation patterns 
of the engrafted cells diverge depending on the injury phase-
specified microenvironment of the damaged spinal cord,14,25,34 
which may be linked to differences in the relative amounts of M1 
and M2 macrophages during the different injury phases.9,11,35,36 
Extracellular factors that specifically regulate fate determination 
of stem cells have been identified successfully by multipotent 
neural stem cells culture.26,27,37 Platelet-derived growth factor 
(PDGF) and neurotrophin-3(NT3) are potent inducers of neu-
ronal production, and thyroid hormone induces oligodendro-
cyte differentiation.38–42 Astrocyte differentiation is promoted by 
both leukemia inhibitory factor (LIF) and ciliary neurotrophic 
factor (CNTF). Other factors, such as bone morphogenetic 
protein (BMP), can enhance both neuronal and astrocyte dif-
ferentiation. The molecular mechanisms that orchestrate these 
sequential are begin to be elucidated. LIF and CNTF exert their 
effects primarily via the JaK/ STAT signaling pathway.41,43 BMP-
induced astrocyte differentiation appears to be mediated by 
downstream Smad signaling proteins.44 A new study revealed 
that neurogenin(Ngn1) represses glial-specific gene transcrip-
tion, mainly by first sequestering the CBP/p300/Smad1 complex 
away from glial promoters, and then blocking the JaK/STAT 
signaling pathway.38,45 Several basic  helix-loop-helix (bHLH) 
transcription factors have been implicated as mediators of neu-
ronal or oligodendrocyte differentiation in the developing CNS. 
These bHLH factors include oligo1 and oligo2 for oligodendro-
cyte specification,46,47 and neurogenin1 and 2 (Ngn1 and Ngn2), 
Mash1, and Math1 for neuronal differentiation.48–50 In addition 
to Olig1/2, it has been reported that Ascl1 also specifies an OPC 
cell fate in telencephalic NPCs at later developmental stages45,51 
and can force an oligodendrocyte fate when overexpressed 
in NPCs of the adult dentate gyrus.52 In the current study, we 
found that M2 macrophages polarized from BMDMs in vitro 
expressed elevated levels of anti-inflammatory cytokines and 
growth factors (see Supplementary Figure S6). Lu et al. previ-
ously showed that growth factors are essential components of a 
fibrinogen matrix cotransplanted with NS/PCs into the injured 
spinal cord.27,28 Consistent with the above observations, we pro-
pose that M2 macrophages can significantly enhance neuronal 
and oligodendrocytic differentiation from NS/PCs, even when 
cotransplanted during the nonoptimal acute injury phase, most 
likely because they secrete growth factors (i.e., PDGF and NT3) 
(see Supplementary Figure S6) that enhance the neuronal dif-
ferentiation of engrafted NS/PCs. Glial-inducing factor leukemia 
inhibitory factor (LIF) probably allows the NS/PCs transplanted 
with M1 macrophages to produce more astrocytes. Although 
our data reveal a distinct difference in the differentiation fate of 
NS/PC depending on whether they are cotransplanted with M1 
or M2 macrophages, further research will be required to obtain 
greater insight into the mechanisms by which these factors mod-
ulate particular cell-fate decisions.
In this study, the cotransplantation of NS/PCs and M2 mac-
rophages clearly promoted functional locomotor recovery. 
Although NC/PC differentiation was biased toward neurons and 
oligodendrocytes in the presence of cotransplanted M2 macro-
phages, >60% of the NS/PC-differentiated cells were astrocytes. 
Further investigation will be required to determine whether NS/
PC differentiation is accompanied by aberrant axonal sprouting 
and allodynia.
Migration from the injection site toward the injury site is a pre-
requisite for successful NS/PC-based therapy for SCI.2 Engrafted 
NS/PC-derived cells translocate both rostrally and caudally dur-
ing the acute and subacute phases of SCI,6,17,37 but here, we showed 
a bias toward rostral migration. Although several chemokines/
cytokines are responsible for the movement of transplanted NS/
PCs in the injured CNS, elevated CXCL12/SDF-1 levels appar-
ently play a central role in recruiting transplanted NS/PCs to the 
lesion site.32 In the spinal cord, the main sources of CXCL12 are 
the dorsal corticospinal tract (dCST) and the meninges.53 The 
expression of CXCL12 does not change rostral to the lesion, but 
disappears caudally from the degenerating dCST.53 This phenom-
enon may explain why we observed preferential migration of the 
transplanted NS/PCs in the rostral direction. Our current results 
indicate a complete reversal of the migratory patterns of engrafted 
NS/PC-derived cells following cotransplantation of NS/PCs with 
M1 versus M2 macrophages. Whereas NS/PC-derived cells exhib-
ited long-distance rostral migration from the site of injection with 
M1 cotransplantation, almost no migration was observed with 
M2 cotransplantation. However, the CXCR4 inhibitor, AMD3100, 
inverted the migration patterns of the engrafted NS/PC-derived 
cells in response to the cotransplanted macrophages. Although 
the precise manner by which the polarized macrophages can 
influence the migration of the engrafted NS/PC-derived cells 
remains unknown, the CXCR4 pathway is the most likely candi-
date signaling mechanism. We found that both M2 macrophages 
and M2-CM-stimulated NS/PCs exhibited high CXCL12 expres-
sion, which possibly prevented the engrafted, CXCR4-expressing 
NS/PCs and their progeny from moving outside the injection site 
and counteracted the attraction from outside CXCL12 sources.53 
By contrast, M1 macrophages and M1-CM-stimulated NS/PCs 
exhibited low CXCL12 and high CXCR4 expression. Therefore, 
the progeny of these NS/PCs are expected to be sensitive to areas 
of high CXCL12 expression, prompting rostral migration as sug-
gested previously.53 Additionally, higher levels of growth factor 
milieu secreted by M2 macrophages (Supplementary Figure S6) 
and the tendency toward neuronal differentiation may also 
have contributed to the limited migration of the engrafted  NS/
PC-derived cells. However, it is unknown whether the adminis-
tration of AMD3100 to block CXCL12/CXCR4 signaling alters 
the differentiation status of M1/M2 macrophages. In summary, 
although it is unclear whether other chemokines (Supplementary 
Figure S5) exert biological effects on the migration of the engrafted 
NS/PC-derived cells, our results suggest strongly that the CXCR4 
pathway is the most likely candidate signaling mechanism.
In conclusion, this study demonstrated that cotransplantation 
of NS/PCs with polarized M2 macrophages into localized sites of 
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tissue damage is a promising strategy for SCI repair. M2 macro-
phages promoted the neuronal differentiation of NS/PCs, restricted 
the movement of the engrafted cells and their progeny to the injec-
tion site, resulting in the replacement of lost cells, and enhanced 
the interactions of engrafted cells and their progeny with host neu-
rons. These macrophage actions and NS/PC responses were facili-
tated by CXCL12/CXCR4 signaling. Nevertheless, further study is 
required to elucidate the cellular mechanisms by which polarized 
macrophages modify both the microenvironment within the dam-
aged spinal cord and the essential properties of the cotransplanted 
NS/PCs to improve functional recovery after SCI.
MATERIALS AND METHODS
Animals. C57BL/6 (B6) and B6/GFP-Tg (transgenic) mice were purchased 
from Shanghai Laboratory Animal Center (Shanghai, China) and were 
bred in our animal facilities. B6/RFP-Tg mice with no obvious defects in 
development were generated by us.22 All housing, surgical, and postop-
erative care procedures were performed in accordance with The Fourth 
Military Medical University Animal Care and Use Committee.
SCI model. Male B6 mice received a severe midthoracic (T8–9) cush 
injury using Dumont type forceps with a spacer of 0.2 mm, as described 
previously.54
Cell culture. Bone marrow-derived macrophage (BMDMs) were gener-
ated as described previously from adult B6 or B6/RFP-Tg mice.55 Briefly, 
bilateral femurs and tibias of mice were flushed using 26-gauge needles 
into DMEM/10%FBS (Gibco, Carlabad, CA). Red blood cells were lysed 
in lysis buffer (0.15 mol/l NH4Cl, 10 mmol/l KHCO3, and 0.1 mmol/l 
Na2EDTA, pH 7.4). Cells were cultured in DMEM supplemented with 1% 
penicillin/streptomycin, 1%HEPES, 0.001% b-mercaptoethanol, 10%FBS, 
and 20% sL929 supernatant from sL929 cells, which secrete macrophage 
 colony-stimulating factor (M-CSF) required for the promotion of bone 
marrow cell differentiation into macrophages (7–10 days).56
Neural progenitor/stem cells (NS/PCs) were established from the 
spinal cord of E14-E15 B6/GFP-Tg mice. Briefly, spinal cords were 
microdissected and stripped of meninges. Then tissues were mechanically 
dissociated into a single cell suspension. Cells were grown as neurospheres 
in serum-free neurobasal medium (Gibco, Karlsruhe, Germany) 
supplemented with 100 μg/ml penicillin/streptomycin (Gibco), 10 mmol/l 
L-glutamine (Gibco), 20 μl/ml B-27 supplement (Gibco), recombinant 
epidermal growth factor (EGF) (20 ng/ml, PeproTech, London, UK), and 
recombinant basic fibroblast growth factor (bFGF) (20 ng/ml, PeproTech).
Macrophage polarization and conditioned medium preparation. 
To promote polarization into M1 or M2 macrophages, BMDMs were 
treated with LPS (100 ng/ml; Sigma-Aldrich, L2630-lipopolysaccharides 
from Escherichia coli 0111:B4) plus IFN-γ (20 ng/ml; Peprotech) or IL-4 
(20 ng/ml; Peprotech), respectively, for 24 hours. Sham control (M0 mac-
rophages) received no treatment except for a change in the macrophage 
medium. Macrophages were stimulated by cultivation for 24 hours in 
medium containing cytokines, after which the supernatants were removed 
and the cells were washed twice with phosphate-buffered saline to remove 
all traces of the tested reagents. Then an equivalent volume of fresh neu-
robasal medium was added to the culture of treated or untreated macro-
phages for another 24 hours. Supernatants were collected as basal culture 
media. The basal media supplemented with 100 μg/ml penicillin/strepto-
mycin (Gibco), 10 mmol/l L-glutamine (Gibco), 20 μl/ml B-27 supplement 
(Gibco), EGF (5 ng/ml, PeproTech) and FGF (5 ng/ml, PeproTech) consti-
tuted the M-CMs including M0-CM, M1-CM, and M2-CM.
NS/PC differentiation in vitro and in vivo. Single cells were harvested 
from the third passaged neurospheres. Differentiation of NS/PCs in vitro 
was initiated by resuspending the cells in the collected M-CMs. To analyze 
the differentiation of NS/PCs in vivo, a mixture of NS/PCs-GFP and mac-
rophage -RFP(1:1, totally 6 × 105) was injected into the injury epicenter 24 
hours after injury. The spinal cords were then collected at 1 day, 3 days, 2 
weeks, 5 weeks, 9 weeks, and 12 weeks after transplantation to check the 
polarization of macrophage -RFP and for the differentiation and migration 
of NS/PCs in vivo.
Cell transplantation. SCI mice described above were randomly divided into 
five implant groups: (i) SCI-only, (ii) NSPCs-GFP+M0-RFP, (iii) NSPCs-
GFP+M1-RFP, (iv) NSPCs-GFP+M2-RFP, (v) NSPCs-GFP only. For trans-
plantation, 6 × 105 mixed cells (NSPCs-GFP: M-RFP 1:1) in 2 μl M-CM were 
injected once into the crushed site (0.2 mm to the right side of the dorsal 
midline, depth of 0.5 mm) using a Hamilton syringe (33G, Hamilton).
Immunocytochemistry and immunohistochemistry. Cover slips and sagit-
tal serial sections (10 µm) (a rostral-caudal extent of 1.5 cm centered on 
the injury site) were fixed with 4% paraformaldehyde for 15 minutes, after 
which blocking solution (2% BSA/0.3% Triton X-100) was applied for 1 
hour at room temperature, followed by the addition of the primary anti-
body (Supplementary Table S1) diluted in blocking solution and incuba-
tion overnight at 4 °C. An appropriate secondary antibody diluted 1:1,000 
were then added and incubated (Jackson ImmunoReasearch Laboratories, 
Dy 488; 594) at room temperature for 2 hours, followed by nuclear staining 
with 4,  6-diamidino-2-phenylindole. The percent of NS/PCs differentiating 
into neurons, oligodendrocytes or astrocytes was determined by counting 
Tuj1/DAPI-, Oligo2/DAPI-, and GFAP/DAPI-positive cells in vitro. The 
number of transplanted cells becoming glia or neurons was determined by 
counting cells coexpressing GFP and MBP/NeuN/GFAP, and then divid-
ing it by the total number of GFP cells labeled with DAPI. Fluorescent 
images were acquired using an Olympus FluoView FV1000 laser scanning 
confocal microscope (Olympus, Tokyo, Japan).
Boyden chamber migration assay. The Boyden chamber migration assay 
was used to evaluate NSC migratory capacity toward M0, M1, or M2 mac-
rophages in vitro. Briefly, a single cell suspension of NS/PCs was seeded 
in upper PLL-coated transwell culture inserts (Nunc) and polarized mac-
rophages were cultured in the lower chamber in NS/PC differentiation 
medium. Cells were allowed to migrate for 24 hours at 37 °C in a moist 5% 
CO2 incubator. Cells that did not migrate on the upper side of the tran-
swell were scraped off and cells that migrated to the bottom of the transwell 
were incubated at room temperature for 30 minutes with hematoxylin and 
eosin for further analysis.
Western blotting. Cells or spinal cord segments (1 cm centered at the 
injury site) were homogenized in lysis buffer (pH 8.0; 50 mmol/l Tris-HCl 
containing 150 mmol/l NaCl, 5 mmol/l ethylenediaminetetraacetic acid, 
1 mmol/l dithiothreitol, 0.5% deoxysodium cholate, 0.1% SDS, 20 μg/ml 
protease inhibitors aprotinin, 1 mmol/l sodium orthovanadate, 1 mmol/l 
mercaptoethanol, and 5 mmol/l sodium fluoride), centrifuged, and the 
supernatants were collected. Protein amounts were determined using the 
Bradford method. Equal amounts of protein from the supernatants were 
denatured at 100 °C for 5 minutes, resolved by 12% SDS-PAGE and trans-
ferred onto a nitrocellulose membrane for 1 hour at 300 mA. The mem-
brane was blocked in 5% nonfat milk for 1 hour and incubated with one of 
the primary antibodies listed in Table 1 overnight at 4 °C. Antibody label-
ling was detected by incubating cultures for 1 hour at room temperature 
with appropriate HRP-conjugated secondary antibodies (1:8,000; Jackson 
ImmunoResearch, West Rove, PA) and visualized with the enhanced 
chemiluminescence kit and the Bio-Rad Image Lab system. Detection of 
β-actin was done to assess equal loading. Densitometric analysis was done 
using Image J software (NIH, Bethesda, MD).
RNA extraction, reverse transcription, and quantitative real-time PCR 
array (qRT-PCR). RNA was isolated via Trizol (Invitrogen, Carlsbad, CA) 
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extraction and reverse transcribed using the SYBR Premix Ex TaaTMII 
kit (DRR036A;TaKaRa, Otsu, Japan), both according to the manufac-
turer’s instructions. We assayed the expression of specific mRNAs using 
Bio-Rad CFX 96 real-time PCR analysis (qRT-PCR; Bio-Rad Laboratories, 
Hercules, CA) with selected gene-specific primer pairs (Supplementary 
Table S2) and SYBR Green master mix (Applied Biosystems) in 20 μl reac-
tions. Expression was normalized to β-actin for each sample.
Behavioral assessment. Behavioral testing (n ≥ 6 for each group) was con-
ducted using a standardized open-field locomotor rating scale (the Basso 
Mouse Scale (BMS)), as previously described.57 Testing was done at 0, 3, 7, 
10, 14, and 21 dpi after cell transplantation.
Statistical analysis. The results are presented as means  ±  the standard 
deviation (SD). Multiple comparisons were done by a one-way analysis of 
variance, followed by Bonferroni’s post hoc test. Results were considered 
statistically significant at P < 0.05. All statistical analyses were conducted 
using SPSS 16.0 software program.
SUPPLEMENTARY MATERIAL
Figure S1. Polarization states of BMDM-derived macrophages 
in vitro.
Figure S2. Gene-specific expression patterns in M1 and M2 
macrophages.
Figure S3. Confirmation of NS/PC identity.
Figure S4. Migratory patterns of engrafted NS/PC-derived cells after 
injection of NS/PCs with and without co-transplanted macrophages 
into the injured spinal cord.
Figure S5. Chemokine expression patterns in macrophages and NS/
PCs.
Figure S6. Expression patterns of growth factors and VCAM in cul-
tured macrophages (*p < 0.05, **p < 0.01, ***p < 0.001).
Figure S7. In vitro expression patterns of CXCR7 in NS/PCs and 
macrophages.
Figure S8. Cytotoxicity analysis of AMD3100.
Figure S9. Migratory patterns of engrafted NS/PC-derived cells after 
co-transplantation of AMD3100-treated NS/PCs and macrophages.
Table S1. Antibodies for IHC.
Table S2. The primer sequences for QRT-PCR analysis.
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